Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
4(27%)
Results Posted
33%(1 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
9
60%
Ph phase_4
1
7%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

4

trials recruiting

Total Trials

15

all time

Status Distribution
Active(6)
Completed(3)
Terminated(2)
Other(4)

Detailed Status

unknown4
Completed3
Recruiting3
Not yet recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
4
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (10.0%)
N/A9 (90.0%)

Trials by Status

completed320%
not_yet_recruiting17%
withdrawn17%
terminated17%
enrolling_by_invitation17%
recruiting320%
active_not_recruiting17%
unknown427%

Recent Activity

4 active trials
Showing 5 of 15
recruitingnot_applicable

Electroporation Treatment for Early AF Management in Heart Failure With Preserved Ejection Fraction (HFpEF) Pilot Study

NCT07385417
enrolling_by_invitationnot_applicable

Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab

NCT06719921
recruiting

Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

NCT06056271
not_yet_recruiting

Complex Arrhythmia Registry

NCT07024927
completed

Prospective Study to Validate Ablation Parameters with MRI Based Scar for Left Atrial Ablation

NCT04363307
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07385417Not Applicable

Electroporation Treatment for Early AF Management in Heart Failure With Preserved Ejection Fraction (HFpEF) Pilot Study

Recruiting
NCT06719921Not Applicable

Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab

Enrolling By Invitation
NCT06056271

Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

Recruiting
NCT07024927

Complex Arrhythmia Registry

Not Yet Recruiting
NCT04363307

Prospective Study to Validate Ablation Parameters with MRI Based Scar for Left Atrial Ablation

Completed
NCT04945746Not Applicable

Dispersion Stability

Active Not Recruiting
NCT05827172Not Applicable

AF Ablation for HF With Reduced EF

Completed
NCT05617456

Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice

Recruiting
NCT04592497Not Applicable

Evaluation of the Safety and Performance of the Very High Power-Short Duration QDOT

Unknown
NCT03370536Not Applicable

ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization

Terminated
NCT03989726Not Applicable

Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patients With Atrial Fibrillation

Unknown
NCT00652522Not Applicable

Atrial Fibrillation Management in Congestive Heart Failure With Ablation

Completed
NCT03607123

Atrial Fibrillation With Sinus Node Dysfunction: Intensive Device Follow-up

Unknown
NCT02768051Not Applicable

Evaluation of the Safety, Feasibility and Usability of the EPD D700 System in Atrial Flutter Ablation Procedures

Withdrawn
NCT01504451Phase 4

Left Atrial Ablation of Paroxysmal Atrial Fibrillation With Implantable Loop Recorder Follow Up Study: The LAAPITUP 2 Study

Unknown

All 15 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
15